The human EGF-like receptor 2 (HER2) is functionally implicated in the pathogenesis of human breast cancer and is an important prognostic and predictive marker in breast cancer (Moasser, 2007; Tapia et al., 2007). Here, ERBB2 is linked to breast carcinoma.